TFS
IDNA icon

TrustCore Financial Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

TrustCore Financial Services’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-205
Closed -$6K – 1110
2022
Q2 		$6K Hold
205
– – ﹤0.01% 822
2022
Q1 		$7K Buy
+205
New +$7.24K ﹤0.01% 811

Other funds holding IDNA

WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

TrustCore Financial Services's IDNA Position: Q3 2022 in Review

TrustCore Financial Services sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2022, closing a stake of 205 shares — an estimated $6K sold.

TrustCore Financial Services first reported a position in IDNA in Q1 2022 and held it in 2 quarters. The position peaked at $7K in Q1 2022. 67 funds tracked by Wall St. Rank hold IDNA as of Q3 2022.

  • TrustCore Financial Services reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 205 iShares Genomics Immunology and Healthcare ETF shares in Q3 2022, an estimated $6K.
  • TrustCore Financial Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2022 and held it in 2 quarters.
  • TrustCore Financial Services's iShares Genomics Immunology and Healthcare ETF position peaked at $7K in Q1 2022.
  • 67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2022.

Based on TrustCore Financial Services's 13F filing for Q3 2022, filed 3 Nov 2022.